Cover Image

Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Taku Fujimura, Kentaro Ohuchi, Tetsuya Ikawa, Yumi Kambayashi, Ryo Amagai, Sadanori Furudate, Yoshihide Asano
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful Control of Langer hans Cell Sarcoma in a Super‐Aged Patient Using Intensity‐Modulated Radiotherapy
by: Hiromu Okuguchi, et al.
Published: (2026)

Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
by: Ryo Amagai, et al.
Published: (2025)

Comprehensive Analysis of the Chemokine/Cytokine Profiles in Advanced Mycosis Fungoides and Atopic Dermatitis
by: Manami Takahashi-Watanabe, et al.
Published: (2025)

Alloantibody to Recombinant ADAMTS13 Reduces Clinical Efficacy in Congenital TTP : An Emerging Therapeutic Concern
by: Kazuya Sakai, et al.
Published: (2026)

Role of gut microbiome in the outcome of lymphoma patients treated with checkpoint inhibitors—The MicroLinf Study
by: Beatrice Casadei, et al.
Published: (2024)

Tissue‐Equivalents of Lymphoid Clonal Hematopoiesis of Indeterminate Potential (L‐CHIP) and Germline‐Derived Lymphoproliferations: Possible Caveats for Hematopathologists
by: Magdalena M. Brune, et al.
Published: (2025)

Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario
by: Antonio Pinto, et al.
Published: (2024)

Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect
by: Jinrong Yang, et al.
Published: (2024)

New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with JAK inhibitors
by: Naseema Gangat, et al.
Published: (2024)

JAK inhibitor treatment‐resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?
by: Maria Chiara Finazzi, et al.
Published: (2024)

GLP‐1 agonists and SGLT‐2 inhibitors in adults with sickle cell disease
by: Ryan Sun, et al.
Published: (2024)

Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia
by: Elias Jabbour, et al.
Published: (2024)

Bruton tyrosine kinase inhibitor monotherapy in B‐cell lymphoma and risk of infection: A systematic review and meta‐analysis of randomized controlled trials
by: Mohammed Zuber, et al.
Published: (2024)

Drug‐induced autoimmune hemolytic anemias related to immune checkpoint inhibitors, therapeutic management, and outcome
by: Marion Plaçais, et al.
Published: (2024)

Prognostic value of the second revision of the international staging system (R2‐ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
by: Taku Kikuchi, et al.
Published: (2024)

Efficacy of escalating therapy with brentuximab vedotin‐AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD
by: Carmen Martínez, et al.
Published: (2024)

Outcomes after treating advanced mantle cell lymphoma in a low‐income group at a Latin American center: The role of outpatient hematopoietic stem cell transplantation
by: José Carlos Jaime‐Pérez, et al.
Published: (2024)

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria
by: Phillip Scheinberg, et al.
Published: (2024)

Successful 13‐year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome
by: Mariam A. Mostafa, et al.
Published: (2024)

Adverse impact of 1q amplification on outcomes in patients with multiple myeloma treated with daratumumab, carfilzomib and dexamethasone in a real‐world clinical setting
by: Taku Kikuchi, et al.
Published: (2024)

Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia
by: Tamer Othman, et al.
Published: (2024)

Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real‐world cohort analysis
by: Adam S. Kittai, et al.
Published: (2024)

592 | SYSTEMIC MALT LYMPHOMA WITH PULMONARY INVOLVEMENT: A MULTI‐INSTITUTIONAL OBSERVATIONAL STUDY IN JAPAN
by: K. Suzuki, et al.
Published: (2025)

Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts
by: Lara Tavernari, et al.
Published: (2024)

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
by: Takashi Watanabe, et al.
Published: (2024)

Allogeneic transplantation for adult T‐cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy
by: Hidehiro Itonaga, et al.
Published: (2024)

Peripheral blood quantitation of CD26 positive leukemic stem cells as a predictor of tyrosine kinase inhibitor response in chronic myeloid leukemia
by: Nitin Chaudhary, et al.
Published: (2024)

FOXO3 suppresses lymphoma progression through promoting miR‐34b/HSPG2 axis
by: Shi Tao, et al.
Published: (2024)

Long‐Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1‐Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy
by: Hidehiro Itonaga, et al.
Published: (2025)

Frozen/Thawed Samples Can Replace Fresh Samples for Assignment of ISI to Secondary Thromboplastin Standards for Multiple Reagent/Instrument Combinations: Data to Support Possible Revision of WHO Guidelines
by: Matthew Kitchen, et al.
Published: (2024)

Treatments and Outcomes of Newly Diagnosed CD5‐Positive Diffuse Large B‐Cell Lymphoma: A Multi‐Institutional Observational Study
by: Yuma Nato, et al.
Published: (2025)

Adverse Impact of Pre‐Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation
by: Yukiko Misaki, et al.
Published: (2025)

Classical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis
by: Kyoko Masuda, et al.
Published: (2025)

Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First Transplantation
by: Kazuki Yoshimura, et al.
Published: (2025)

Loss‐Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia
by: Yoshitaka Zaimoku, et al.
Published: (2025)

Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study
by: Naoki Kurita, et al.
Published: (2025)

Different impacts of granulocyte colony‐stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft type
by: Takaaki Konuma, et al.
Published: (2024)

Risk Factors for and Impact of Pre‐Engraftment Syndrome on Outcomes Following Single‐Unit Cord Blood Transplantation in Adults
by: Masatoshi Sakurai, et al.
Published: (2025)

A Japanese Case of Marie Unna Hereditary Hypotrichosis With a HRURF Gene Variant
by: Jun Yamamoto, et al.
Published: (2026)

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma
by: Juliette Penichoux, et al.
Published: (2025)